GunjanLalitchandraShahMDMS

PubMed

• Unscheduled healthcare interactions in multiple myeloma patients receiving T cell redirection therapies.
  Anna J Howard, Isabel Concepcion, Alice X Wang, Issam S Hamadeh, Malin L Hultcrantz, Sham Mailankody, Carlyn Rose Tan, Neha Korde, Alexander M Lesokhin, Hani Hassoun, ...> ;Blood Advances. 2024 Apr 12
• Patterns of CRS with Teclistamab in Relapsed/Refractory Multiple Myeloma patients with Prior T-Cell Redirection Therapy.
  Issam S Hamadeh, Tala Shekarkhand, Colin Joseph Rueda, Ross S Firestone, Alice X Wang, Neha Korde, Malin L Hultcrantz, Alexander M Lesokhin, Sham Mailankody, Hani Hass...> ;Blood Advances. 2024 Apr 10
• 1 citations
  CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma.
  Ross S Firestone, Devin McAvoy, Tala Shekarkhand, Edith Serrano, Issam Hamadeh, Alice Wang, Menglei Zhu, Wei Ge Qin, Dhwani Patel, Carlyn R Tan, Malin Hultcrantz, Sham...> ;Blood Advances. 2024 Apr 9
• Hospital healthcare resource utilization and costs for chimeric antigen T-cell therapy and autologous hematopoietic cell transplant in patients with large B-cell lymph...
  Chendi Cui, Chaoling Feng, Ning Rosenthal, Sally W Wade, Laura Curry, Christine Fu, Gunjan L Shah> ;Leukemia & Lymphoma. 2024 Apr 3
• BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cel...
  Robert Stuver, Agrima Mian, Samantha Brown, Sean Devlin, Paolo F Caimi, Stephanie Chinapen, Parastoo Dahi, Robert Dean, Zachary D Epstein-Peterson, Brian Hill, Steven ...> ;American Journal of Hematology. 2024 Mar 25
• Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation.
  Melica, G., Preston, E., Palazzo, M., Seier, K., Malard, F., Devlin, S., Maloy, M., Borrill, T., Cho, C., Maslak, P., Shah, G., Perales, M.> ;Bone Marrow Transplantation. 2024 Feb 13
• Measurement of ThioTEPA and Its Metabolite TEPA in Plasma and Cerebrospinal Fluid by Turbulent Flow Chromatography-Tandem Mass Spectrometry.
  Ryan C Schofield, Michael Scordo, Gunjan Shah, Dean C Carlow> ;Methods in Molecular Biology. 2024 Jan 1
• Quantification of Clofarabine and Fludarabine in Plasma by High-Performance Liquid Chromatography-Tandem Mass Spectrometry.
  Ryan C Schofield, Michael Scordo, Gunjan Shah, Dean C Carlow> ;Methods in Molecular Biology. 2024 Jan 1
• Simultaneous Determination of Prednisone and Prednisolone in Serum by Turbulent Flow Liquid Chromatography-Tandem Mass Spectrometry.
  Ryan C Schofield, Michael Scordo, Gunjan Shah, Dean C Carlow> ;Methods in Molecular Biology. 2024 Jan 1
• Determination of Busulfan and Melphalan in Plasma by Turbulent Flow Chromatography-Tandem Mass Spectrometry.
  Ryan C Schofield, Michael Scordo, Gunjan Shah, Dean C Carlow> ;Methods in Molecular Biology. 2024 Jan 1
• Autologous hematopoietic stem cell transplantation for multiple myeloma in the age of CAR T cell therapy.
  Charlotte F M Hughes, Gunjan L Shah, Barry A Paul> ;Frontiers in Oncology. 2024 Jan 1
• Optimizing high dose melphalan.
  Shah, G., Giralt, S., Dahi, P.> ;Blood Reviews. 2024 Mar 1
• 3 citations
  Chimeric Antigen Receptor T Cell Therapy for Myeloma: Where Are We Now and What Is Needed to Move Chimeric Antigen Receptor T Cells Forward to Earlier Lines of Therapy...
  Larry D Anderson Jr, Binod Dhakal, Tania Jain, Olalekan O Oluwole, Gunjan L Shah, Surbhi Sidana, Miguel-Angel Perales, Marcelo C Pasquini> ;Transplantation and Cellular Therapy. 2024 Jan 1
• Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy.
  Maria-Stefania Infante, David Nemirovsky, Sean Devlin, Susan DeWolf, Roni Tamari, Parastoo B Dahi, Yeon Joo Lee, David J Chung, Ioannis Politikos, Juliet Barker, Sergi...> ;Transplantation and Cellular Therapy. 2024 Jan 1
• 1 citations
  Reduced-Intensity Compared to Nonmyeloablative Conditioning in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
  Karthik Nath, Kristen Peterson, Samantha Brown, Sean Devlin, Natasia Rodriguez, Juliet Barker, Sergio Giralt, Boglarka Gyurkocza, Ann Jakubowski, Esperanza Papadopoulo...> ;Transplantation and Cellular Therapy. 2024 Jan 1
• Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation.
  Roni Tamari, Michael Scordo, Binni M Kunvarjee, Anthony Proli, Andrew Lin, Jessica Flynn, Christina Cho, Sean Devlin, Elizabeth Klein, Farid Boulad, Maria I Cancio, Ke...> ;Blood Advances. 2023 Sep 26
• Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphoma.
  Parastoo B Dahi, Sheila Kenny, Jessica Flynn, Sean M Devlin, Josel D Ruiz, Stephanie A Chinapen, Oscar B Lahoud, Matthew J Matasar, Craig H Moskowitz, Miguel-Angel Per...> ;Leukemia & Lymphoma. 2023 Dec 1
• 2 citations
  The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantation.
  Shlomo Elias, Samantha Brown, Sean M Devlin, Juliet N Barker, Christina Cho, David J Chung, Parastoo B Dahi, Sergio Giralt, Boglarka Gyurkocza, Ann A Jakubowski, Oscar...> ;British Journal of Haematology. 2023 Dec 1
• Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma.
  Carlyn Rose Tan, Andriy Derkach, David Nemirovsky, Amanda Ciardiello, Benjamin Diamond, Malin Hultcrantz, Hani Hassoun, Sham Mailankody, Urvi Shah, Kylee Maclachlan, D...> ;Blood Cancer Journal. 2023 Jul 25
• 4 citations
  Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphoma.
  Richard J Lin, Soo Jung Kim, Samantha Brown, Theresa A Elko, Josel D Ruiz, Danielle M Hanley, M Lia Palomba, Miguel-Angel Perales, Gunjan L Shah, Parastoo B Dahi, Mich...> ;Blood Advances. 2023 Jul 25
• 13 citations
  CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results.
  Jae H Park, Karthik Nath, Sean M Devlin, Craig S Sauter, M Lia Palomba, Gunjan Shah, Parastoo Dahi, Richard J Lin, Michael Scordo, Miguel-Angel Perales, Roni Shouval, ...> ;Nature Medicine. 2023 Jul 1
• 2 citations
  Patient Characteristics and Outcomes of Outpatient Tisagenlecleucel Recipients for B Cell Non-Hodgkin Lymphoma.
  Mushtaq, M., Nausheen Ahmed, William Wesson, Muhammad Umair Mushtaq, David L Porter, Sunita D Nasta, Jamie Brower, Veronika Bachanova, Marie Hu, Loretta J Nastoupil, O...> ;Transplantation and Cellular Therapy. 2023 Jul 1
• 5 citations
  Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy pat...
  Justin C Laracy, Judy Yan, Samantha N Steiger, Carrie A Tan, Nina Cohen, Elizabeth V Robilotti, Jerome Fender, Sara Cohen, Neha Korde, Melissa Lee-Teh, Ariela Noy, Jos...> ;Haematologica. 2023 Nov 1
• 2 citations
  A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma.
  Mwanasha H Merrill, Parastoo B Dahi, Robert A Redd, Mikaela M McDonough, Yi-Bin Chen, Zachariah DeFilipp, Alex F Herrera, David C Fisher, Ann S LaCasce, Oreofe O Odeji...> ;Blood. 2023 Aug 17
• 2 citations
  Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantation.
  Michael Scordo, Leah J Gilbert, Danielle M Hanley, Jessica R Flynn, Sean M Devlin, Linh K Nguyen, Josel D Ruiz, Gunjan L Shah, Craig S Sauter, David J Chung, Heather J...> ;Blood Advances. 2023 Apr 25
• Join now to see all

Abstracts/Posters

• Early Experience Using Radiotherapy As a Salvage Treatment for Relapsed or Refractory Non-Hodgkin Lymphomas Following CD19 Chimeric Antigen Receptor Modified T-Cell Th...
  Gunjan L. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Long-Term Follow-up Confirms Durability of Single-Agent Brentuximab Vedotin As Pre-Transplant Salvage for Classical Hodgkin Lymphoma
  Gunjan L. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Easix and Modified-Easix Are Early Predictors of Severe Cytokine Release Syndrome and Neurotoxicity in Patients Treated with Chimeric Antigen Receptor T Cells
  Gunjan L. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Pre-Transplant Fecal Microbial Diversity Independently Predicts Critical Illness after Hematopoietic Cell Transplantation
  Gunjan L. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Multiple Myeloma Patients Treated with Lenalidomide Maintenance Therapy: A Clinical and Correlative Ph...
  Gunjan Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Difference in Involved and Uninvolved Free Light Chain (dFLC) of Less Than 1mg/DL Early Post Risk Adapted Melphalan and Autologous Stem Cell Transplantation (RA-ASCT) ...
  Gunjan L. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• MSKCC Early Experience Using Radiotherapy As a Bridging Strategy for Relapsed Diffuse Large B Cell Lymphoma before CD19 CAR T Therapy
  Gunjan L. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Weekly Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab (wKRd-D) Combination Therapy Provides Unprecedented MRD Negativity Rates in Newly Diagnosed Multiple My...
  Gunjan Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed ...
  Gunjan L. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Medicare Patients Receiving Chimeric Antigen Receptor T-Cell Therapy for Non-Hodgkin Lymphoma: A First Real-World Look at Patient Characteristics, Healthcare Utilizati...
  Gunjan L. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Multiple Myeloma Patients Treated with Lenalidomide Maintenance Therapy: A Clinical and Correlative Ph...
  Gunjan Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Hematological Count Recovery in Patients Undergoing Treatment with Chimeric Antigen Receptor T Cells (CAR T)
  Gunjan L. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Phase II, Multicenter Study of High Dose Chemotherapy with Autologous Stem Cell Transplant Followed By Maintenance Therapy with Romidepsin for T-Cell Lymphoma
  Gunjan L. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Impact and Safety of Chimeric Antigen Receptor T Cell Therapy in Vulnerable Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
  Gunjan L. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Comparing Gradings of Immune Effector Cells Toxicities: Application of Astct Consensus Grading System and Implications for Clinical Management
  Gunjan L. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Homebound Autologous Hematopoietic Cell Transplantation for Plasma Cell Disorders in an Urban Setting Is Safe for Patients and Preferred By Patients and Caregivers 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Survival for Relapsed/Refractory Hodgkin Lymphoma Patients with Recurrent or Persistent Disease Following Autologous Hematopoietic Stem Cell Transplantation Treated in... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Double-Unit Cord Blood (CB) Transplantation with Haplo-Identical CD34+ Cells (haplo-dCBT) May Speed Neutrophil Recovery Although Successful Bridging Is Contingent on C... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Impact of CD34 Cell Dose Infused on the Duration of Absolute Neutropenia after High Dose Melphalan and Autologous HCT for Myeloma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Dysgeusia Is Associated with Higher Melphalan Pharmacokinetic Levels and Results in Poorer Caloric Intake and Worse Symptom Burden after Autologous Stem Cell Transplan... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all